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he role of collaborations in research has become more dominant with the 
passage of time. This should not be surprising given the evolution of the study 
of biomedical problems. If we look back to the middle of the last century, 
research was very different. Problems were more basic – we had just begun to 
recognize and understand the genome and molecular biology was yet to be invented; 
the tools for research were relatively rudimentary – the electron microscope, which 
ultimately revolutionized cell biology, was just beginning to enjoy widespread use; 
and the questions investigators asked were very much framed by their discipline; 
most researchers were trained in a single area, and applied a single technique to just 
one aspect of a problem. The pressure to pursue an integrated approach was 
minimal.  
This began to change rapidly in the 
latter part of the 20th century. Problems 
became more complex, with larger 
available armamentaria with which to 
pursue these questions. Of course, with 
more advanced technologies and a 
greater desire to incorporate 
multidisciplinary approaches in 
attacking biomedical problems, also 
came challenges. Training began to lag 
behind technology; it became difficult to 
find individuals whose breadth of 
technical skills was suitable to bring to 
bear upon the full range of emerging 
medical questions. Clearly, the easiest 
way to achieve the necessary critical 
mass of technologies and disciplines was 
through research collaborations. 
While a need for creating research 
collaborations has been recognized for 
some time, the magnitude of 
collaborations necessary for advancing 
biomedical research has continued to 
grow with the increasing complexities of 
the questions at hand. We have seen the 
norm in academic collaborations grow 
from simple ad hoc associations that 
develop in a grass-roots manner, to the 
creation of research teams in more 
formal settings. While this model is 
widely applied in the commercial and 
government sectors, it has been late in 
coming to academia, owing to several 
reasons. In large part, this may be 
attributed to a number of logistical 
issues that have to be overcome in order 
to successfully develop collaborative 
T 
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research teams. Some of these issues are 
as follows. 
• Identifying target areas. There 
need to be clearly defined and 
agreed upon target areas that will 
provide a framework in which 
collaborative research programs 
can develop and grow. 
• Growing the investigator base. In 
order to attain meaningful 
collaborative teams, it is essential 
to have sufficient strength to 
draw upon so that teams with the 
appropriate expertise are in 
place. This may involve either 
identifying existing potential 
members, or recruiting members 
to join the sponsoring institution 
• Creating group cohesion and a 
common cause. A collaborative 
group needs to see a common 
vision. If the programmatic 
direction is unclear, if the vision 
is unshared, or if the outcome of 
the collaboration is vague or in 
dispute, collaborative research 
will suffer. However, 
mechanisms must also be in 
place to permit adjustments to 
programmatic direction that take 
into account changes in strength 
due to the addition of new 
members or the loss of existing 
members. 
• Thinking regionally. Given the 
range of approaches that can be 
potentially applied to biomedical 
research problems, it is becoming 
more likely that collaborations 
beyond the walls of any given 
academic institution become 
necessary; this is especially true 
of smaller institutions. These 
types of collaborations raise a 
new set of issues; bridging 
institutional barriers, distribution 
of resources, and overcoming 
problems associated with 
distance between institutions are 
chief among these. 
How can we encourage 
development of regional collaborative 
research enterprises? There are probably 
a large number of potential approaches, 
and there clearly is no absolute formula 
that can guarantee success. However, we 
have been fortunate in having some 
success in developing collaborative 
programs, and our model may be 
instructive to others who may wish to 
replicate the experience – or perhaps 
learn from our mistakes! 
Role of a Research Center in 
developing collaborations 
The University of Kansas was 
fortunate in 1966 to be one of an elite 
handful of universities to be awarded 
funds from the newly formed National 
Institute for Child Health and Human 
Development (NICHD) to create a 
Mental Retardation Research Center 
(MRRC). KU, under the leadership of 
Richard Schiefelbusch, was one of 
twelve original host sites for sponsoring 
these MRRCs. The objective of these 
centers was to promote research in 
mental retardation and other disabilities 
affecting the nervous system and 
behavior. While the objective of this NIH 
P30 grant was not to initiate research 
collaborations per se, the award did a 
number of important things in easing us 
along this path. One factor was that it 
required us to identify and develop 
research themes. Each center is expected 
to have areas of research emphasis 
relevant to mental retardation and 
developmental disabilities (MRDD). In 
our case, we began with a substantial 
number – originally in excess of 8. What 
is somewhat surprising is that, rather 
than increasing the numbers of themes 
over time as might be expected to occur 
with normal institutional growth, the 
number actually decreased. It appears 
that some Darwinian processes may be 
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at hand, favoring the perpetuation of 
some themes and the demise of others. 
There may be several reasons for 
this. One is clearly related to leadership. 
Those themes that had strong leaders 
remained viable, while those where a 
clear leader was less obvious did not 
prove to be durable. A second factor 
appears to be related to group drift. 
Stronger groups, while perhaps not 
intentionally meaning to, often times 
absorb members of the weaker groups. 
This may be associated with people 
gravitating to the stronger leaders, but is 
also seems that thriving programs may 
provide greater opportunities – and 
some of these are in the form of potential 
collaborations.  Because of a need to 
define themes, the MRRC grant 
formalized and legitimized potential 
collaborative areas and identified and 
empowered group leaders to move these 
areas forward. So while the major thrust 
of the MRRC grant was not to develop 
research collaborations per se, it was 
probably inevitable that this should have 
been the case.  
These principles seem aptly 
illustrated with regard to the evolution 
of the R.L. Smith Research Center, the 
Kansas City branch of the MRRC (the 
component with which I am most 
familiar). A new building constructed 
for the purpose of housing MRRC 
programs in common space (although 
that capacity was rapidly exceeded) 
opened in 1972. In the initial brochure 
describing Smith Center, 6 thematic 
areas were listed. 
» Reproductive physiology & 
Neuroendocrinology  
» Human Genetics 
» Developmental Physiology 
» Impaired fetal & infant 
development 
» Neurobiological mechanisms 
» Educational and Pediatric 
psychology 
Through the pressures described 
above, the fates of these areas changed 
over the next decade and a half. Thus, by 
the mid-1980’s, the number of thematic 
research areas had diminished 
essentially to 2: biology of early 
development (reproductive biology) and 
neurobiology of intellectual disabilities. 
Why did this occur? One probable 
reason is that maintaining so many 
divisions requires considerable effort. 
Another is that not all areas had the 
mass necessary to sustain (some likely 
created to induce participation by 
catering to territorial wants, thus slicing 
the pie rather thinly). In some cases, key 
individuals left for other positions. One 
factor accounting for the durability of 
the two surviving themes was that they 
were inherently more inclusive, ably 
accommodating many members of the 
smaller original groupings. And perhaps 
most importantly, both remaining 
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divisions were able to identify strong 
leaders who were able to consolidate 
groups of researchers. Gilbert 
Greenwald, chair of physiology, was 
able to bring together and organize a 
growing number of reproductive 
biology researchers and, similarly, Fred 
Samson, Director of the Smith Center, 
served in a similar role in promoting 
neurosciences. Both of these leaders 
were in positions to effect recruitments 
in their respective areas, thus increasing 
numbers of collaborating researcher, as 
well as in organizing existing faculty. 
While our original organizers 
clearly played critical roles, the 
importance of continuity in leadership 
should not be underestimated. In both 
cases, when the time came to pass the 
mantle, there were relatively clear lines 
of ascension, with Paul Terranova (now 
vice chancellor for research) stepping in 
to lead the reproductive sciences group, 
and Paul Cheney (now chair of 
molecular and integrative physiology) 
assuming direction of the Smith Center 
and representing the neurosciences 
group. Continued group cohesion is 
highly dependent on having potential 
incumbent leaders in the wings that are 
able to step in when conditions dictate. 
As a result of the activities of the 
MRRC, research on the KUMC campus 
was impacted very significantly by 
laying down groundwork for organized 
research collaborations in 2 areas that 
have persisted over the years. And 
indeed, over the years the payoffs have 
been substantial. These are probably best 
illustrated in the area of reproductive 
sciences. In the past decade or so, there 
have been several program project 
grants that have come out of the 
reproductive sciences group. Very 
significantly, we have seen center grants 
(initially a P30 and subsequently a U54) 
in reproductive sciences and now in 
male contraception come directly from 
this group, as well as an Institute for 
Maternal and Fetal Biology. Thus, in the 
case of reproductive sciences, the MRRC 
served as an incubator in which a 
number of newer sub-themes re-
emerged, building on the collaborations 
that were encouraged by the structure of 
the Mental Retardation Research Center 
grant (see article by Paul Terranova, p. 
5). 
Role of an Institute in developing 
regional research collaborations 
The successes of the MRRC 
(subsequently renamed the Eunice K. 
Shriver Kansas Intellectual and 
Developmental Disabilities Research 
Center [KIDDRC] in 2007) have been 
substantial and impressive. However, 
there were some limitations that, in the 
evolving environment, are likely to have 
impeded regional research 
collaborations. While the NICHD center 
grant (P30) mechanism was essential in 
encouraging the establishment of core 
groups in reproductive biology and 
neuroscience at KUMC, the ground 
rules, by their very nature, also limited 
the evolution of these groups.  
Centers funded by the NIH are 
intended to serve a specific purpose. In 
the case of the IDDRCs, they are 
intended to “…advance the diagnosis, 
prevention, treatment, and amelioration 
of intellectual and developmental 
disabilities.”(http://grants.nih.gov/grant
s/guide/rfa-files/RFA-HD-08-016.html). 
This requirement immediately places 
constraints on the types of research that 
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can be included in the IDDRC portfolio. 
Further, membership within the IDDRC 
research themes is not open to all 
investigators. Thus, the purpose of the 
IDDR center grant is to provide core 
technical, scientific and administrative 
support investigators with funded 
research programs related to forms of 
intellectual and/or developmental 
disabilities. Because this is the mission of 
the NICHD and this Institute is footing 
the bill, it is totally appropriate that 
activities be selectively supported. But 
this also places restrictions on the types 
of interactions that can occur. Thus, 
interactions with investigators who have 
related or complimentary funded 
research programs, but which are not 
ostensibly relevant to IDD, are not 
encouraged by this model. Similarly, 
those with programs that are relevant 
but not currently funded are also not 
supported. Further, because the center is 
based on a single-institution model, 
individuals who have relevant programs 
within the region but outside of the 
parent institution are not encouraged to 
participate. And finally, because many 
clinicians with interests and patient 
populations relevant to IDDRC thematic 
areas lack requisite funding, interactions 
with these clinician-investigators are 
impeded by the P30 model. While there 
is a strong rationale for having these 
guidelines in place, it is also clear that 
these strictures can impede a research 
center from evolving to the next level of 
being a base for regional clinical and 
basic biomedical research. 
How can these limitations be 
circumvented? The need for alternative 
strategies to broaden the collaborative 
research base has been an issue of 
particular relevance to neuroscientists at 
the University of Kansas Medical Center. 
Basic neuroscience research has been a 
powerhouse at KUMC for some time, 
owing much of its success to the 
organizational framework created by the 
MRRC. In 2008, KUMC had some 40 
scientists with programs related to the 
neurosciences, and with a funding 
portfolio of approximately $70 M. 
Perhaps another 80 basic scientists and 
clinicians were present at KUMC or 
regionally. Yet the Neurobiology theme 
of the IDDRC at this time included only 
19 members! Clearly, there was a strong 
need to create an alternative 
infrastructure that would be more 
inclusive if we wanted to foster stronger 
interactions among basic and clinical 
researchers in the neurosciences. This 
led to the conceptualization of a regional 
entity to better accommodate 
collaborations: the Institute for 
Neurological Disorders (IND). 
The decision to move forward with 
the IND represented a convergence of 
multiple factors. An important 
component was a strategy on the part of 
KUMC administration to more clearly 
articulate its priorities and goals for the 
next 10 years. The result of that effort 
was a document entitled “The Time is 
Now”(http://www.kumc.edu/evc/TheTi
meIsNow.pdf), in which existent 
strengths in the neurosciences were 
acknowledged, making this discipline 
one of the top priorities. In response to a 
need to better organize the neuroscience 
effort, departmental chairs and center 
directors in programs relevant to the 
neurosciences convened and formed a 
plan to create the Institute for 
Neurological Disorders. Several features 
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of the IND were put in place to 
maximize collaborative output. 
• A regional entity; no walls. An 
important aspect of the IND is 
that, while it is based at 
KUMC, all regional 
neuroscientists can be members 
and participate. This 
recognizes not only the fact 
that the Kansas City 
neuroscience community exists 
in many relatively small 
institutions, each lacking 
desirable critical programmatic 
mass, but also that in many 
instances such collaborations 
had already been established at 
the grass roots level. 
• A place for clinicians as well as 
basic sciences. In the current 
atmosphere where the highest 
value is placed on 
‘translational’ activities, it is 
essential that the full range of 
biomedical activities, from 
discovery to application, be 
represented. Accordingly, it is 
important to include members 
in both the clinical and basic 
sciences arenas. 
• Organization by discipline; 
finding common threads. 
Neuroscience is an extremely 
broad field, and a particular 
challenge was to identify a 
finite and manageable number 
of working groups where 
essentially all individuals 
within our broad neuroscience 
community could belong. We 
elected to establish 6 divisions 
within the IND which would 
be inclusive of members with 
common interests. Importantly, 
we wished to encourage 
further evolution of each of 
these groups, such that with 
additional resources and 
organization, the division may 
ultimately be elevated to 
‘Center’ status. 
• Disorders as a focus. While 
bench neuroscientists relish the 
idea of studying mechanisms 
of axoplasmic flow or neuronal 
phenotype maintenance for the 
sake of understanding the basic 
biology, the reality is that just 
about everyone else is focused 
on the disease. In fact, it really 
is all about improving quality 
of life and finding preventions 
and cures for diseases. We 
have therefore identified 
specific diseases where we 
have sufficient expertise to 
justify the claim that a 
collaborative research team 
exists. Accordingly, our efforts 
are targeted toward some 22 
specific disorders where such 
strengths exist.  
With these defining principles in 
mind, the IND was organized and 
launched in March 2009, nearly a year 
after it was first conceived. Our primary 
IND Divisions
1. Brain Injury and Repair
2. Neuromuscular and Movement Disorders
3. Neurodegenerative Disorders
4. Hearing and Equilibrium Disorders
5. Female Pain Syndromes
6. Cognitive and Behavioral Neuroscience
Disease Focus Areas
• Addiction & Impulse 
Control
• Alzheimer’s & other 
dementias
• Amyotrophic lateral 
sclerosis
• Autism and intellectual 
disabilities
• Behavioral and 
psychiatric disorders
• Epilepsy
• Fibromyalgia
• Hearing loss
• Huntington’s Disease 
• Parkinson’s Disease 
• Pelvic pain
• Peripheral neuropathy
• Migraine & TMJ
• Multiple Sclerosis
• Myasthenia Gravis
• Myopathies
• Spinal Cord Injury
• Stroke
• Tinnitus
• Traumatic Brain Injury
• Tremors
• Vertigo & balance disorders
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objective was to advance neuroscience 
translational research programs 
regionally by coordinating and 
consolidating basic and clinical research. 
To do so, we identified 7 specific aims. 
1. Provide administrative 
structure. Very little gets done 
without significant 
administrative input. By 
partnering with existing 
administrative units, it was 
possible for the IND to rapidly 
establish the administrative 
structure necessary to maintain 
communication among 
members and to coordinate 
events. 
2. Promote interactions & 
communication. As noted 
above, communication follows 
directly from having an 
administrative infrastructure in 
place. In addition, we’ve 
developed mechanisms that 
seek to promote 
communication among IND 
members (see discussion of 
Translational Discovery 
Forums below). Arguably, this 
may be the single most 
important element necessary 
for creating cohesion and 
collaboration. 
3. Recruit researchers. The IND is 
playing a major role in the 
recruitment of neuroscience 
researchers. Perhaps the most 
significant advantage offered 
by the Institute offers is to 
bring together multiple 
partners working toward a 
common goal. In these days of 
limited resources, it is 
increasingly important that 
departments and centers who 
share similar needs work 
together to identify the mean 
necessary for successfully 
recruiting the right candidate. 
The IND has become an 
integral player in the 
neuroscience recruitment 
process, first by helping to 
identify the appropriate target 
recruitment area, and then by 
brokering arrangements 
whereby multiple departments 
and centers contribute 
resources toward the planned 
recruitment. 
4. Promote core technologies. The 
IND can play a substantive role 
in promoting technologies 
within the neuroscience 
community in two important 
ways. First, its multi-
institutional composition puts 
it in an excellent position to 
promote and coordinate core 
technologies available 
throughout the Kansas City 
region. In addition, the IND 
can play a major role in 
identifying areas of 
technological deficiencies, and 
then mustering resources 
necessary to incorporate these 
technologies into existing or 
new cores.  
5. Graduate programs 
enhancements. The IND, 
because of its organizational 
structure, serves as an adjunct 
to graduate education in the 
realms of both coursework and 
training programs. Our 
organizational structure into 
divisions is highly conducive to 
course development, and 
effectively provides a set of 
faculty who would be qualified 
to provide lectures in the 
related areas. Moreover, the 
IND with its extensive 
membership and access to core 
and individual laboratory 
technologies, is an attractive 
partner in formulating a 
predoctoral training program 
application and is likely to be 
viewed as a plus by a peer 
review committee. Because of 
its multi-institutional nature 
and communications web, 
neuroscientists throughout the 
region are made aware of new 
courses originating in 
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conjunction with the IND and 
therefore are in a better 
position to inform their 
students of educational 
opportunities available to 
them, even if they are not 
currently attending the KUMC 
program. 
6. Commercialization pipelines.  
The field of neuroscience is 
fertile ground for development 
of patents and commercial 
products. Through enhanced 
collaborations, 
multidisciplinary interactions, 
and close ties with drug 
development programs and 
offices of intellectual property, 
the IND is well positioned to 
encourage commercialization 
of neuroscience-related drugs 
and devices. 
7. Integrated space. Because the 
IND embraces members from 6 
different institutions, the 
probability of ever 
consolidating all members in a 
single building is low. 
Nonetheless, having a single 
building dedicated to bringing 
together basic and clinical 
neuroscientists and that can be 
identified as the home of the 
IND would do well to advance 
the concept of the Institute. 
Translational Discovery Forums: A 
vehicle for clinical-basic conversations 
A significant challenge in 
promoting translational research 
programs is developing a means of 
communication among individuals with 
convergent interests. All too often, 
clinicians have limited exposure to basic 
scientists and do not attend common 
functions. While individuals may have 
similar interests, often times the clinical 
or basic researchers are unaware of 
ongoing related activities across the 
street. The objective in creating 
Translational Discovery Forums ( TDFs) 
was to provide a vehicle that would 
bring together established scientists and 
trainees, clinicians and basic researchers, 
to share interests and ideas in a setting 
that encourages interactions. 
Our TDFs consist of interactions 
centered around a discipline or 
collaborative approach to a neurological 
disorder (a few of the topics to date 
include peripheral neuropathy, 
fibromyalgia, multiple sclerosis, 
Alzheimer’s disease, and epilepsy). We 
typically hold these late Friday 
afternoon, which seems to be a time 
most compatible with the schedules of 
both clinicians and basic science faculty. 
The format is as follows: 
• Clinical presentation. An 
overview of the disorder that 
forms the basis for the TDF is 
presented or, alternatively a case 
history or even patient 
presentations have formed the 
basis for this half-hour session. 
These are presented by a student, 
fellow or attending physician. 
• Basic science journal 
presentation. This component 
integrates the established 
Neuroscience Journal Club. A 
student in the neurosciences 
selects a paper relevant to the 
disorder under discussion and 
presents this to the audience. The 
emphasis in this half-hour 
segment is to stress the 
relationship of the research to 
advancing our understanding of 
the disease. 
• Collaborative research 
presentation. This forms the core 
of the TDF. Basic scientists and 
clinicians with common interests 
in a specific disorder present 
their research program relevant 
to the disease. They are strongly 
encouraged to describe ongoing 
collaborations and clinical-basic 
interactions or, if these are not in 
place, then the areas where 
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collaborations could occur are 
described in this one-hour 
session. Bringing in members 
from different institutions is 
strongly encouraged. 
These simple monthly forums have 
received a remarkable level of interest 
and turned out to be quite effective. 
Basic scientists frequently work on a 
disease process without fully 
understanding the clinical perspective, 
and therefore especially appreciate the 
introductory clinical overview. 
Similarly, clinicians often are not aware 
of how basic science can be brought to 
bear in investigating disease 
mechanisms or treatments, and are often 
surprised at how revealing some basic 
science publications may be to disease 
mechanisms. However, the greatest 
impact seems to be in the process of 
organizing the collaborative research 
presentation. Because these need to 
represent a coordinated effort, those 
presenting are encouraged to meet well 
before the scheduled TDF to discuss 
their presentations. In some cases where 
an existing collaboration is in place, 
there may be few surprises, and a 
history of how the collaboration evolved 
is instructive to those groups that are not 
as far along. However, in a number of 
cases these meetings have tended to be 
revelational, where obvious areas of 
collaboration emerge and light bulbs are 
turned on. Importantly, TDFs are open 
to anyone who wants to come, including 
patients with interest in the disorder. 
Accordingly, we encourage presenters to 
take a very basic approach and avoid the 
technical or jargon-laden tour de force 
approach, thus making these 
presentations more accessible to all in 
attendance. 
Partnerships with existing 
programs 
One area of collaborative evolution 
that has become increasingly important 
over the past decade or so is the extent 
to which independent programs must 
now partner with others. The pressures 
to partner were probably less evident in 
earlier times of more abundant 
resources, but it is now clear that an 
economy of scale can be beneficial. 
Typically, independent programs have 
common interests and needs, and there 
is little advantage in duplicating existing 
resources that may already have the 
capacity to serve additional purposes. 
 Given that the IND in many ways 
originated from within the Kansas 
IDDRC, it will not be surprising that 
these 2 entities are closely aligned and 
are partnering in areas of intersecting 
interest. However, the IND has also 
sought partnerships with other 
programs as well. These include: 
• The Heartland Institute for 
Clinical and Translational 
Research. The HICTR serves as 
the primary regional instrument 
for advancing translational 
research in Kansas City, and 
serves as the organizing force 
behind an application for a 
Clinical and Translational 
Sciences Award. There are clearly 
a large number of intersecting 
objectives between the HICTR 
and IND, and the IND serves to 
organize neuroscience activities 
within the HICTR. 
• The Kansas IDeA Network for 
Biomedical Research Excellence. 
This state-wide program funded 
by the NIH National Center for 
Research Resources is intended 
to promote educational and 
research programs, with 
emphasis on cell and 
developmental biology. There are 
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several areas where their 
interests converge with those of 
the IND, particularly in regard to 
core services, and areas of 
common interest continue to 
evolve. 
• Departments with strengths in 
neurosciences. Several 
departments have strong 
programs in the neurosciences 
and the IND is committed to 
working closely with these 
toward common goals. A 
particularly strong area of 
convergence pertains to 
recruitments. Because 
institutionally all faculty 
appointments are made through 
departments, the  IND is highly 
dependent on close interactions 
in this regard. However, the IND 
has emerged as a particularly 
important player in recruitments 
by serving as a brokerage to 
bring together multiple players, 
as larger home for neuroscience 
recruits, and for providing 
assistance to clinical departments 
wishing to expand their research 
base. 
• Center on Aging and the 
Hoglund Brain Imaging Center. 
The IND has much in common 
with other centers that support 
neuroscience clinical and basic 
activities. As with the 
departments, the IND has helped 
in recruitments and in organizing 
research programs and the 
Centers have provided access to 
programs and core technologies 
that have served to advance the 
regional neuroscience effort. 
• The KU Endowment Association. 
Philanthropic support represents 
an increasingly important 
mechanism for promoting 
research programs. Private or 
foundation donations can 
support a number of important 
functions, including research 
starter funds for generating 
preliminary data prior to 
applying for NIH funding, 
named lectureships, scholarships 
and fellowships, endowed 
professorships, and institute or 
center directorships.  
Conclusions 
The IND, barely 6 months old at the 
time of this writing, remains a young 
and developing entity. Much remains to 
be done, and many challenges are yet to 
be overcome. However, the progress to 
date has been very encouraging. IND 
membership now exceeds 120 members, 
with membership in individual 
Divisions ranging from about 10 to 55. 
About half of our members are clinicians 
or clinician-scientists. While the majority 
is located at KUMC, we have members 
from all major regional institutions. We 
have been successful in brokering one 
major recruitment and are exploring the 
possibility of a second. Our  TDFs 
continue monthly, and are very highly 
attended. Clearly, the true metrics for 
success will come in the form of new 
collaborations leading to grants, papers, 
and other evidence of scientific 
advancement. Such outcomes take time, 
so we do not yet know the extent of the 
impact of the IND. Nonetheless, we have 
seen in several instances new 
collaborations arise, often unexpectedly 
and frequently across institutional 
boundaries. The IND therefore seems to 
be providing an effective vehicle for 
moving quickly into a new era of 
enhanced regional collaborations within 
the Kansas City area. 
